Blueprint Medicines Corp Sustainability Reports

Blueprint Medicines Corporation is a biopharmaceutical company focused on developing highly selective kinase inhibitors and precision therapies. Its primary focus areas include targeted therapies for allergy, inflammation, oncology, and hematology diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 5299004CC60O9T5HVM83

FIGI: BBG001V11BV0

4 reports from 2021 to 2024

• Blueprint Medicines Corp 2024 Sustainability Highlights
• Blueprint Medicines Corp 2023 Sustainability Report
• Blueprint Medicines Corp 2022 Corporate Responsibility Report
• Blueprint Medicines Corp 2021 Corporate Responsibility Report